Liu Bing, Si Wen, Wei Bo, Zhang Xuan, Chen Peng
Department of Stomatology, Air Force Medical Center of Chinese PLA, Beijing, 100142, China.
Department of Medical Oncology, Beijing Shijitan Hospital affiliated to Capital Medical University, Beijing, 100038, China.
Cell Death Discov. 2023 Sep 29;9(1):360. doi: 10.1038/s41420-023-01657-x.
PTP4A1 (Protein tyrosine phosphatase 4A1) is a protein tyrosine phosphatase that regulates a range of pro-oncogenic signaling pathways. Here, we report a novel role for PTP4A1 in oral squamous cell carcinoma (OSCC) growth and development. We show that PTP4A1 is frequently overexpressed in OSCC cells and tissues compared to adjacent non-tumor tissue. In OSCC, the overexpression of PTP4A1 increased cell growth and invasion in vitro, and enhanced tumor progression in vivo. At the molecular level, PTP4A1 was found to regulate mitochondrial metabolic reprogramming to enhance the invasive capacity of OSCC cells. Mechanistically, these effects were mediated through binding to pyruvate kinase isoenzyme M2 (PKM2) to promote its expression and aconitase 2 (ACO2) to enhance its degradation. Together, these data reveal PTP4A1 as a viable target for OSCC therapeutics.
PTP4A1(蛋白酪氨酸磷酸酶4A1)是一种蛋白酪氨酸磷酸酶,可调节一系列促癌信号通路。在此,我们报告了PTP4A1在口腔鳞状细胞癌(OSCC)生长和发展中的新作用。我们发现,与相邻的非肿瘤组织相比,PTP4A1在OSCC细胞和组织中经常过度表达。在OSCC中,PTP4A1的过表达在体外增加了细胞生长和侵袭,并在体内增强了肿瘤进展。在分子水平上,发现PTP4A1调节线粒体代谢重编程以增强OSCC细胞的侵袭能力。机制上,这些作用是通过与丙酮酸激酶同工酶M2(PKM2)结合以促进其表达以及与顺乌头酸酶2(ACO2)结合以增强其降解来介导的。总之,这些数据揭示PTP4A1是OSCC治疗的一个可行靶点。